BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04700124-completion@plaintrial.com
DTSTAMP:20261029T024212Z
DTSTART;VALUE=DATE:20251027
SUMMARY:Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) 
 Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bla
 dder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) — estimated compl
 etion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04700124
URL:https://plaintrial.com/trial/NCT04700124
END:VEVENT
END:VCALENDAR